Medical News

RSS

NC State researchers help design affordable sanitary pads from local, organic materials

For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.

5 Oct 2009

ZYNEX obtains accreditation as a Medicare DMEPOS supplier

Zynex, Inc. a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has obtained accreditation as a Medicare DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) supplier, as required to maintain its status as provider to Medicare and several private health insurance companies.

5 Oct 2009

Also in Global Health news: World Bank budget concerns; Ethiopia prepares for malaria surge; malnutrition in Yemen; malaria prevention in Africa

Before the start of the annual meetings of the World Bank and International Monetary Fund World Bank on Friday, World Bank President Robert Zoellick warned that the international lender expects to "face serious constraints" by the middle of next year unless developed nations provide the bank with more resources, the Associated Press reports.

5 Oct 2009

HealthCare Insight launches new care management program for oncology claims

HealthCare Insight, a division of Verisk Health, Inc., and a provider of clinically validated fraud, abuse, and overpayment prevention solutions for private and public-sector payors, announced today the release of a new care management program for oncology claims.

5 Oct 2009

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.

5 Oct 2009

Today's editorials and opinions

The Senate Finance Committee put the final touches on its healthcare bill early Friday morning, and soon Democratic leaders will begin reconciling it with a more costly alternative approved by the Senate's health panel.

5 Oct 2009

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Bristol-Myers Squibb Company and AstraZeneca announced today that the European Commission has granted marketing authorisation for ONGLYZATM in the 27 countries of the European Union.

5 Oct 2009

Challenges surround the calculation of costs associated with illegal immigrant care

PhillyBurbs.com examines the cost of caring for undocumented immigrants and whether it really is cheaper to exclude them under a health care overhaul. Despite widespread support for requiring people to prove their citizenship to receive government health benefits, PhillyBurbs.com reports: "Public health and immigration experts worry excluding undocumented immigrants would put everyone at risk, hamper attempts to prevent the spread of disease and lead to an increase in health care spending."

5 Oct 2009

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced today that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV.

5 Oct 2009

Medicaid expansion proposal continues to worry governors

The Washington Post: "The nation's governors are emerging as a formidable lobbying force as health-care reform moves through Congress and states overburdened by the recession brace for the daunting prospect of providing coverage to millions of low-income residents.

5 Oct 2009

San Francisco’s public option receives high marks

The Los Angeles Times reports on San Francisco's public option: "Over the last two years, three-quarters of San Francisco's uninsured adults have enrolled in a public program that guarantees access to medical services, an effort that is being touted as a national model during the rancorous debate over healthcare reform.

5 Oct 2009

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.

5 Oct 2009

Lawmakers plan to finance health reform with Medicare cuts, much to seniors' dismay

Lawmakers are planning to pay for much of their plans to expand coverage to the uninsured by slowing Medicare spending by as much as $500 billion over 10 years, Long Island Newsday reports. Democrats say the only thing the cuts "take out of Medicare is waste" - in the words of Senate Majority Leader Harry Reid, - but Republicans who oppose the Democrat-led reform effort have warned that cuts will reduce services for seniors.

5 Oct 2009

Sonora Medical Systems sold to Medical Imaging Holdings for $8 million

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.

5 Oct 2009

Nursing home industry: New funding cuts will force closures

"The nation's nursing homes are perilously close to laying off workers, cutting services — possibly even closing — because of a perfect storm wallop from the recession and deep federal and state government spending cuts, industry experts say," The Associated Press reports.

5 Oct 2009

Snowe, some Democrats hesitate to support finance reform package

The Wall Street Journal reports that Sen. Olympia Snowe of Maine continues to be a key swing vote as the Senate Finance Committee wraps up its work in its health bill version and prepares to move it to the Senate floor. "Early Friday, Ms. Snowe said she was not sure how she would vote. 'I've got to review the document and go from there,' she said of the revised bill.

5 Oct 2009

ArQule completes patient enrollment in ARQ 197 Phase 2 trial for non-small cell lung cancer

ArQule, Inc. (Nasdaq: ARQL) today announced that patient enrollment in a Phase 2 trial with ARQ 197 in non-small cell lung cancer (NSCLC) has been completed.

5 Oct 2009

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.

5 Oct 2009

Alnara to announce Phase 3 study results of liprotamase for treating cystic fibrosis at the 23rd NACFC

Alnara Pharmaceuticals, Inc., a pharmaceutical company developing novel, non-systemic orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that results from a landmark, international Phase 3 study of the long-term safety and nutritional benefits of liprotamase for the treatment of pancreatic insufficiency in patients with cystic fibrosis (CF) will be presented at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) being held October 15-17, 2009 in Minneapolis, Minnesota.

5 Oct 2009

Bon-Ton Stores to conduct “Shop for a Cure” event to support breast cancer research

The Bon-Ton Stores, Inc. announced today the official kick-off to National Breast Cancer Awareness Month with special promotions to support breast cancer research. On Wednesday, October 7, Bon-Ton will hold a “Shop for a Cure” one-day shopping event. The Company will donate 1% of all purchases made on its proprietary credit card on October 7 to fund breast cancer research.

5 Oct 2009

Medical News

NC State researchers help design affordable sanitary pads from local, organic materials

ZYNEX obtains accreditation as a Medicare DMEPOS supplier

Also in Global Health news: World Bank budget concerns; Ethiopia prepares for malaria surge; malnutrition in Yemen; malaria prevention in Africa

HealthCare Insight launches new care management program for oncology claims

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

Today's editorials and opinions

Bristol-Myers Squibb and AstraZeneca receive marketing authorisation for ONGLYZA in Europe

Challenges surround the calculation of costs associated with illegal immigrant care

LA BioMed granted $1.3M for investigating ESAI's KRONOS IV in correcting erectile dysfunction

Medicaid expansion proposal continues to worry governors

San Francisco’s public option receives high marks

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

Lawmakers plan to finance health reform with Medicare cuts, much to seniors' dismay

Sonora Medical Systems sold to Medical Imaging Holdings for $8 million

Nursing home industry: New funding cuts will force closures

Snowe, some Democrats hesitate to support finance reform package

ArQule completes patient enrollment in ARQ 197 Phase 2 trial for non-small cell lung cancer

Bausch & Lomb announces acquisition of Tubilux Pharma's commercial assets

Alnara to announce Phase 3 study results of liprotamase for treating cystic fibrosis at the 23rd NACFC

Bon-Ton Stores to conduct “Shop for a Cure” event to support breast cancer research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News